Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
Journal of gastrointestinal and liver diseases : JGLD
Munteanu M, Ratziu V, Morra R, Messous D, Imbert-Bismut F, Poynard T
2008 J Gastrointestin Liver Dis Volume 17 Issue 2
Review FibroTest ActiTest SteatoTest NashTest AshTest HCV HBV HIV co-infected Metabolic Diseases Alcohol Fibrosis Steatosis Activity/Inflammation Diabetes Hypertension OverWeight HyperLipidemia
Citation Reference: